Search

Cordoba Lab

Publications

List of all publications "Cordoba-Chacon" PI of Cordoba Lab

Below are indicated publications directly derived from the projects of Cordoba Lab, and others in which our lab played a major role.

Year	Title	Authors	Journal, volume, pages
2023	Role of hepatic peroxisome proliferator-activated receptor γ in non-alcoholic fatty liver disease	Lee SM, Muratalla J, Sierra-Cruz M, Cordoba-Chacon J	J Endocrinol 10;257(1):e220155.
2023	Hepatocyte PPARγ contributes to the progression of non-alcoholic steatohepatitis in male and female obese mice	Lee SM, Muratalla J, Karimi S, Diaz-Ruiz A, Frutos MD, Guzman G, Ramos-Molina B, Cordoba-Chacon J	Cellular and Molecular Life Sciences 11;80(2):39.
2021	Rosiglitazone requires hepatocyte PPARγ expression to promote steatosis in male mice with diet-induced obesity.	Lee SM, Muratalla J, Diaz-Ruiz A, Remon-Ruiz P, McCann M, Liew CW, Kineman RD, Cordoba-Chacon J	Endocrinology. 162(11):bqab175.
2021	Hepatocyte-specific loss of PPARg protects mice from NASH, and increases the therapeutic effects of rosiglitazone in the liver.	Lee SM, Pusec CM, Norris GH, De Jesus A, Diaz-Ruiz A, Muratalla J, Sarmento Cabral A, Guzman G, Layden BT, Cordoba-Chacon J.	Cellular and Molecular Gastroenterology and Hepatology. 11(5):1291-1311
2020	Loss of Hepatocyte-Specific PPAR γ Expression Ameliorates Early Events of Steatohepatitis in Mice Fed the Methionine and Choline-Deficient Diet	Cordoba-Chacon J	PPAR Res 2020:9735083
2019	Tissue-dependent effects of cis-9, trans-11- and trans-10, cis-12-CLA isomers on glucose and lipid metabolism in adult male mice.	Cordoba-Chacon J, Sugasini D, Yalagala PCR, Tummala A, White ZC, Nagao T, Kineman RD, Subbaiah PV.	J Nutr Biochem. 67:90-100
2019	Hepatic HKDC1 Expression Contributes to Liver Metabolism.	Pusec CM, De Jesus A, Khan MW, Terry AR, Ludvik AE, Xu K, Giancola N, Pervaiz H, Daviau Smith E, Ding X, Harrison S, Chandel NS, Becker TC, Hay N, Ardehali H, Cordoba-Chacon J, Layden BT.	Endocrinology. 160(2):313-330.
2018	Adult-Onset Hepatocyte GH Resistance Promotes NASH in Male Mice, Without Severe Systemic Metabolic Dysfunction.	Cordoba-Chacon J, Sarmento-Cabral A, Del Rio-Moreno M, Diaz-Ruiz A, Subbaiah PV, Kineman RD.	Endocrinology. 159(11):3761-3774.
2017	Hepatocyte-specific, PPARγ-regulated mechanisms to promote steatosis in adult mice.	Wolf Greenstein A, Majumdar N, Yang P, Subbaiah PV, Kineman RD, Cordoba-Chacon J.	J Endocrinol. 232(1):107-121.
2016	Growth Hormone Control of Hepatic Lipid Metabolism.	Liu Z, Cordoba-Chacon J, Kineman RD, Cronstein BN, Muzumdar R, Gong Z, Werner H, Yakar S.	Diabetes. 65(12):3598-3609.
2016	Hepatic PPARγ Is Not Essential for the Rapid Development of Steatosis After Loss of Hepatic GH Signaling, in Adult Male Mice.	Kineman RD, Majumdar N, Subbaiah PV, Cordoba-Chacon J.	Endocrinology. 157(5):1728-35.
2015	Growth Hormone Inhibits Hepatic De Novo Lipogenesis in Adult Mice.	Cordoba-Chacon J, Majumdar N, List EO, Diaz-Ruiz A, Frank SJ, Manzano A, Bartrons R, Puchowicz M, Kopchick JJ, Kineman RD.	Diabetes. 64(9):3093-103.
2014	Differential impact of selective GH deficiency and endogenous GH excess on insulin-mediated actions in muscle and liver of male mice.	Cordoba-Chacon J, Gahete MD, McGuinness OP, Kineman RD.	Am J Physiol Endocrinol Metab. 307(10):E928-34.